Maryam Parviz

Novartis-trained Ph.D. Toxicologist and Senior R&D Executive with 20+ years defining global safety assessment strategies, leading FDA/EMA/PMDA regulatory submissions, and pioneering New Approach Methodologies (NAMs). Serves as the strategic interface between early discovery chemistry and development safety to de-risk portfolios and accelerate Development Candidate (DC) nominations across diverse therapeutic areas and modalities (small molecules, biologics, novel cell platforms).

Accomplished matrix leader skilled in building high-performing scientific teams and directing complex toxicology programs for global biopharma clients and federal partners (DARPA, Novartis).

Founder & Principal Scientist - The Center for Network Cybernetics - Global / Remote

(2021-01)

• Direct nonclinical portfolio safety strategy and toxicology assessments for global biopharma partners, bridging early discovery chemistry with late-stage development pipelines.
• Lead cross-functional matrix teams deploying advanced CNS electrophysiology, MEA screening platforms, and human-relevant New Approach Methodologies (NAMs) across diverse modalities.
• Architect proprietary simulation engines and automated drug-screening frameworks powered by mathematically unified kinetic decay models (T50 and T90) to de-risk candidate pipelines.
• Provide executive-level advisory and protocol validation to biopharma clients and venture entities transitioning from traditional animal models to human-relevant functional assays.

Principal Consultant - Private Consultant – Regulatory Affairs & Healthcare Compliance - United States

(2014-01)

• Deliver nonclinical safety and regulatory strategy to global biotech organizations, ensuring compliance across international regulatory frameworks (FDA, EMA, PMDA).
• Guide clients through complex regulatory pathways including IND, CTA, NDA, BLA, MAA, 510(k), and PMA filings.
• Design comprehensive preclinical study plans, protocols, scopes of work, and CRO oversight frameworks for multi-organ safety evaluations.

Director of Operations & Medical Affairs - PhyCare, LLC - Dallas, Texas

(2014-01 - 2018-12)

• Managed daily corporate operations, Standard Operating Procedures (SOPs), compliance frameworks, and medical affairs.
• Directed client relationships with healthcare company leaders and delivered executive-level strategic presentations to industry stakeholders.

President & Founder - ZelleTek, LLC / Xerxes Research Group - Frisco, Texas

(2008-01 - 2014-12)

• Founded and led a biotech startup delivering real-time neurobiosensor cell screening and safety analysis for drug development and bio-threat detection.
• Maintained technical leadership while collaborating with the Center for Network Neuroscience at the University of North Texas on spontaneously active neuronal network recording platforms.

Owner, President & Director of Pharmacy Operations - Pharmaceutical Products of America, Inc. - Richardson, Texas

(2013-01 - 2014-12)

• Managed daily pharmacy operations, employee oversight, strict regulatory compliance, and compounded medication development to optimize safety and efficacy.

Scientific Director of Toxicology Studies (DARPA Project) / Clinical Trial Director / Lecturer - University of North Texas / Center for Network Neuroscience - Denton, Texas

(2007-01 - 2012-12)

• Directed nonclinical toxicology studies investigating medical device safety for a high-priority DARPA-funded program.
• Directed strategic planning, study design, and regulatory compliance for clinical trials in Speech and Hearing Sciences.
• Taught undergraduate and graduate coursework in Biochemistry, Contemporary Biology, and Biological Sciences.

Senior Toxicologist / Study Director - Alcon, a Novartis Company - Fort Worth, Texas

(2007-01 - 2010-12)

• Served as Senior Study Director for preclinical acute, subacute, and chronic safety and toxicity evaluations of therapeutic products.
• Ensured strict compliance with FDA, EMEA, USDA, and Japanese (PMDA) regulatory guidelines across internal research and global CRO vendor audits (Covance, Charles River, etc.).
• Completed Good Laboratory Practices (GLP) training and certification from West Coast Quality Training Institute.

Doctor of Philosophy (PhD) - Molecular Biology (Neuroscience) - University of North Texas

Master of Science (MS) - Applied Cognition & Neuroscience - The University of Texas at Dallas

Bachelor of Science (BS) - Neuroscience - The University of Texas at Dallas